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Introduction {#sec005}
============

Human autoimmune diseases are a group of pathologies that cause clinical damage or destruction of body tissue due to an immune response to its own antigens \[[@pone.0198693.ref001], [@pone.0198693.ref002]\]. There are many types of autoimmune diseases, such as SSC (systemic sclerosis), JIA (juvenile idiopathic arthritis), BD (Behcet's disease), RA (rheumatoid arthritis), MS (multiple sclerosis), GD (Graves' disease), SLE (systemic lupus erythematosus), and TID (type 1 diabetes) \[[@pone.0198693.ref001], [@pone.0198693.ref002]\]. A few cytokine genes have been reported to be linked to the autoimmune disease \[[@pone.0198693.ref002]--[@pone.0198693.ref004]\].

Interleukin 1 (IL1), including interleukin 1 alpha (α), beta (β) and receptor antagonist (ra), is a family of cytokines implicated in regulation of the inflammatory response and the incidence of clinical immune disease \[[@pone.0198693.ref005], [@pone.0198693.ref006]\]. The human interleukin 1 alpha (*IL1A*) gene, located on chromosome 2q13 \[[@pone.0198693.ref007]\], contains some common single nucleotide polymorphisms (SNPs), including rs1800587 (NM_000575.4:c.-949`C>T`)and rs17561 (NM_000575.4:c.340`G>T`), which have been reported to be linked to several autoimmune diseases in some populations \[[@pone.0198693.ref008]--[@pone.0198693.ref011]\]. However, negative conclusions have also been obtained by some studies \[[@pone.0198693.ref012]--[@pone.0198693.ref015]\].

Several meta-analyses have reported an association between *IL1A* rs17561, rs1800587 polymorphisms and the presence of various autoimmune diseases, including systemic lupus erythematosus \[[@pone.0198693.ref016], [@pone.0198693.ref017]\], rheumatoid arthritis \[[@pone.0198693.ref018]\], multiple sclerosis \[[@pone.0198693.ref019]\] and Graves' disease \[[@pone.0198693.ref020]\]. However, the genetic relationship between *IL1A* SNPs and the risk of other autoimmune diseases, including systemic sclerosis and type 1 diabetes, has not been reported. In the present study, we probed the genetic role of *IL1A* gene SNPs rs17561 and rs1800587 in the risk of autoimmune diseases using quantitative synthesis of overall meta-analysis followed by subgroup analyses.

Methods {#sec006}
=======

The meta-analysis was conducted per the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines \[[@pone.0198693.ref021]\]. [S1 File](#pone.0198693.s012){ref-type="supplementary-material"} illustrates the meta-analysis on genetic association studies checklist, and [S2 File](#pone.0198693.s013){ref-type="supplementary-material"} shows the PRISMA 2009 checklist.

Database searching {#sec007}
------------------

We obtained potentially suitable articles by systematically searching three databases (up to April 2018): PubMed, WOS (Web of Science), and Embase (Excerpta Medica Database). The search terms were shown in [S3 File](#pone.0198693.s014){ref-type="supplementary-material"}.

Article screening {#sec008}
-----------------

The following screening items were used to exclude publications: duplicates, reviews, letters, meta-analysis, abstracts or posters, and studies with unrelated data. Each study should have investigated an association between *IL1A* gene polymorphisms and autoimmune disease risk. The genotype frequency data could be extracted from both case and control groups. We also performed a chi-square-based Q-test to confirm that the genotype distribution of control group was consistent with HWE (Hardy-Weinberg Equilibrium).

Data extraction {#sec009}
---------------

Detailed data, including the first author name, publication year, SNP, disease type, genotype frequency, genotyping assay, and ethnicity, were extracted and summarized independently. Conflicting data were discussed with all authors, and missing data were requested by e-mail. We also used the Newcastle-Ottawa Scale (NOS) system to assess the study quality and generate an NOS score. An NOS score \< 5 means the study was poor quality, and such studies were excluded.

Statistical association analysis {#sec010}
--------------------------------

Stata/SE 12.0 software (StataCorp, USA) was used. To evaluate the strength of genetic relationships, *P*~*association*~, pooled ORs (odd ratios), and 95% CI (confidence interval) were generated referring to relevant publications \[[@pone.0198693.ref022]--[@pone.0198693.ref026]\]. The *P*~*association*~ value was then adjusted by the Bonferroni and false discovery rate (FDR) correction method \[[@pone.0198693.ref027]\], using R software version 3.4.3. Bonferroni and FDR-corrected *P*~association~ \<0.05 from the association test was considered statistically significant. Six comparison models were utilized: allele `T` vs. `G` for rs17561, allele `T` vs. `C` for rs1800587 (allele); carrier `T` vs. `G` for rs17561, carrier `T` vs. `C` for rs1800587 (carrier); `TT` vs. `GG` for rs17561, `TT` vs. `CC` for rs1800587 (homozygote); `GT` vs. `GG` for rs17561, `CT` vs. `CC` for rs1800587 (heterozygote); `GT`+`TT` vs. GG for rs17561, `CT`+`TT` vs.`CC` for rs1800587 (dominant); `TT` vs. `GG`+`GT` for rs17561, and `TT` vs. `CC`+`CT` for rs1800587 (recessive). We also performed the subgroup analyses according to the characteristics of ethnicity, disease type, and control source.

Q statistics with *P*~heterogeneity~ (P value of heterogeneity) and I^2^ tests with I^2^ values were conducted to assess heterogeneity among the studies. When *P*~heterogeneity~ was \>0.05 and the I^2^ value was \<50%, the absence of high heterogeneity was inferred, and a fixed-effects model (Mantel-Haenszel method) was applied. Otherwise, a random-effects model (DerSimonian and Laird method) was utilized.

Sensitivity analysis and bias evaluation {#sec011}
----------------------------------------

We performed sensitivity analysis to test whether the pooled results were stable. In sensitivity analysis, the effect of each study on the pooled ORs was evaluated as each included study was excluded one-by-one. We also performed Begg's test and Egger's test to evaluate publication bias. *P* values of Begg's test and Egger's test, namely *P*~Begg~ and *P*~Egger~, below 0.05 indicate the absence of publication bias.

Results {#sec012}
=======

Study characteristics {#sec013}
---------------------

As shown in [Fig 1](#pone.0198693.g001){ref-type="fig"}, we searched three databases, identified a total of 240 articles \[PubMed (n = 53), WOS (n = 81), Embase (n = 106)\], and subsequently removed 45 duplicate articles. Then, 150 articles were excluded by our screening criteria. Assessing the eligibility of the remaining 45 articles, ten articles were removed, because seven did not contain complete genotype data and three were not consistent with HWE. Eventually, a total of 35 articles \[[@pone.0198693.ref008]--[@pone.0198693.ref015], [@pone.0198693.ref020], [@pone.0198693.ref028]--[@pone.0198693.ref053]\] were included, and none exhibited poor quality (all NOS score \> 5). We list the characteristics of these studies in [Table 1](#pone.0198693.t001){ref-type="table"}.

![Flow diagram of database searching and article screening.](pone.0198693.g001){#pone.0198693.g001}

10.1371/journal.pone.0198693.t001

###### Characteristics of eligible studies in meta-analysis.

![](pone.0198693.t001){#pone.0198693.t001g}

  First author, year   SNP         Disease   case   control   Source   Assay   NOS   Ethnicity                                                                
  -------------------- ----------- --------- ------ --------- -------- ------- ----- ----------- ---- ----------------------------------------------- ------- -----------
  Abtahi, 2015         rs1800587   SSc       82     72        16       98      98    21          PB   PCR-SSP                                         seven   Asian
  Aggarwal, 2012       rs1800587   JIA       42     47        5        93      78    14          PB   PCR-RFLP                                        seven   Asian
  Akman, 2008          rs1800587   BD        32     17        4        19      22    7           PB   PCR-SSP Tray/Minitray and String Kits           seven   Caucasian
  Beretta, 2007        rs1800587   SSc       117    70        17       112     76    16          PB   PCR-SSP                                         eight   Caucasian
  Crilly, 2000         rs1800587   RA        45     47        7        33      22    5           PB   PCR-RFLP                                        six     Caucasian
  Dominguez, 2017      rs1800587   RA        53     22        5        36      39    5           PB   PCR                                             eight   Caucasian
                       rs17561     RA        55     21        4        47      29    4           PB   PCR                                             eight   Caucasian
  Donn, 2001           rs1800587   JIA       183    125       22       105     113   18          PB   PCR-RFLP                                        six     Caucasian
  Ferri, 2000          rs1800587   MS        189    177       33       198     203   38          PB   PCR-RFLP                                        eight   Caucasian
  Genevay, 2002        rs17561     RA        105    101       24       76      60    8           PB   PCR                                             six     Caucasian
  Harrison, 2008       rs1800587   RA        355    321       63       286     269   49          PB   PCR                                             eight   Caucasian
  Havemose, 2007       rs1800587   JIA       5      3         2        14      10    1           PB   PCR-RFLP                                        seven   Caucasian
  Havemose, 2007       rs1800587   RA        10     7         6        14      10    1           PB   PCR-RFLP                                        seven   Caucasian
  Havemose, 2007       rs17561     JIA       5      3         2        14      10    1           PB   PCR-RFLP                                        seven   Caucasian
  Havemose, 2007       rs17561     RA        10     7         6        14      10    1           PB   PCR-RFLP                                        seven   Caucasian
  Hooper, 2003         rs1800587   MS        189    239       64       102     105   21          PB   PCR-RFLP                                        seven   Caucasian
  Hutyrova, 2004       rs1800587   SSc       17     23        6        87      49    14          PB   PCR-SSP                                         seven   Caucasian
  Johnsen, 2008        rs1800587   RA        687    507       89       546     445   105         PB   primer extension of multiplex products          eight   Caucasian
                       rs17561     RA        686    513       87       545     443   104         PB   primer extension of multiplex products          eight   Caucasian
  Kaijzel, 2002        rs17561     RA        194    171       31       117     79    22          PB   PCR-RFLP                                        seven   Caucasian
  Kammoun, 2007        rs1800587   GD        89     42        0        188     37    0           PB   PCR-RFLP                                        six     African
  Karasneh, 2003       rs1800587   BD        76     44        8        45      49    11          PB   gene sequencing                                 six     Caucasian
  Kawaguchi, 2003      rs1800587   SSc       54     6         0        38      24    8           PB   gene sequencing                                 seven   Asian
                       rs17561     SSc       54     6         0        30      30    10          PB   gene sequencing                                 seven   Asian
  Khalilzadeh, 2009    rs1800587   GD        23     57        27       62      62    12          PB   PCR-SSP                                         seven   Asian
  Kobayashi, 2007a     rs17561     RA        66     19        1        84      15    1           PB   PCR-RFLP                                        seven   Asian
  Kobayashi, 2007b     rs17561     SLE       24     1         0        37      7     0           PB   PCR-RFLP                                        nine    Asian
  Kobayashi, 2009      rs17561     RA        116    20        1        91      16    1           PB   PCR-RFLP                                        eight   Asian
  Liu, 2010            rs1800587   GD        617    137       5        638     92    3           PB   GenomeLab SNPstream 12-plex Genotyping System   seven   Asian
  Mann, 2002           rs1800587   MS        169    152       39       68      64    11          HB   PCR-RFLP                                        five    Caucasian
  Mattuzzi, 2007       rs1800587   SSc       43     28        7        364     275   50          PB   Taqman MGB probes                               seven   Caucasian
  McDowell, 1995       rs1800587   RA        108    127       34       51      37    11          PB   gene sequencing                                 eight   Caucasian
  Mirowska, 2011       rs17561     MS        106    107       15       87      90    16          PB   PCR-RFLP                                        six     Caucasian
  Parks, 2004          rs1800587   SLE       62     57        25       18      43    12          PB   PCR-RFLP                                        seven   African
                                             43     32        11       68      109   25          PB   PCR-RFLP                                        seven   Caucasian
  Pehlivan, 2011       rs1800587   ITP       53     18        0        67      4     0           PB   PCR-RFLP                                        eight   Caucasian
  Sánchez, 2006        rs1800587   SLE       220    164       33       209     166   45          PB   gene sequencing                                 seven   Caucasian
  Sarial, 2008         rs1800587   MS        33     66        1        62      62    12          PB   PCR-SSP                                         six     Asian
  Tahmasebi, 2013      rs1800587   SLE       87     103       16       95      93    21          PB   PCR-SSP                                         seven   Asian
  Zhou, 2016           rs1800587   TID       171    140       21       209     112   11          PB   TaqMan allelic discrimination assay             seven   Asian
                                   JIA       23     27        3        62      62    12          PB   PCR-SSP                                         six     Asian
  Ziaee, 2014          rs1800587   SLE       26     25        7        62      62    12          PB   PCR-SSP                                         six     Asian

**Note:** SNP, single nucleotide polymorphisms; SSC, systemic sclerosis; JIA, juvenile idiopathic arthritis; BD, Behcet's disease; RA, rheumatoid arthritis; MS, multiple sclerosis; GD, Graves' disease; SLE, systemic lupus erythematosus; ITP, immune thrombocytopenic purpura; TID, type 1 diabetes; AA, major allele/major allele; AB, major allele/minor allele; BB, minor allele/minor allele; PB, population-based; HB, hospital-based; PCR-SSP, polymerase chain reaction with sequence-specific primers; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism; NOS, Newcastle-Ottawa Scale.

Meta-analysis of rs17561 {#sec014}
------------------------

Eleven case-control studies with 2,561 cases and 2,099 controls were enrolled for the meta-analysis of the *IL1A* rs17561 G/T polymorphism. As shown in [Table 2](#pone.0198693.t002){ref-type="table"}, compared with controls, no increased risk was detected in any of the cases under six comparison models, including allele `T` vs. `G` \[*P*~*association*~ (*P* value in test of association) = 0.576, Bonferroni-corrected *P*~association~ = 1.000, FDR-corrected *P*~*association*~ = 0.703\]; carrier `T` vs. `G` (*P*~*association*~ = 0.586, Bonferroni-corrected *P*~association~ = 1.000, FDR-corrected *P*~*association*~ = 0.703); `TT` vs. `GG` (*P*~*association*~ = 0.909, Bonferroni-corrected *P*~association~ = 1.000, FDR-corrected *P*~*association*~ = 0.909); `GT` vs. `GG` (*P*~*association*~ = 0.419, Bonferroni-corrected *P*~association~ = 1.000, FDR-corrected *P*~*association*~ = 0.703); `GT`+`TT` vs. `GG` (*P*~*association*~ = 0.438, Bonferroni-corrected *P*~association~ = 1.000, FDR-corrected *P*~*association*~ = 0.703); `TT` vs. `GG`+`GT` (*P*~*association*~ = 0.043, Bonferroni-corrected *P*~association~ = 1.000, FDR-corrected *P*~*association*~ = 0.258). Forest plot data of the meta-analyses under different models are provided in [Fig 2](#pone.0198693.g002){ref-type="fig"} and [S1](#pone.0198693.s001){ref-type="supplementary-material"}--[S5](#pone.0198693.s005){ref-type="supplementary-material"} Figs. We also performed subgroup analyses by ethnicity and disease types. Similar negative results were obtained under different comparison models (all *P*~*association*~\>0.05, Bonferroni-corrected *P*~association~ \>0.05, FDR-corrected *P*~*association*~\>0.05, [Table 3](#pone.0198693.t003){ref-type="table"}), except for the Asian (*P*~*association*~ = 0.024, Bonferroni-corrected *P*~association~ = 0.144, FDR-corrected *P*~*association*~ = 0.048) and PB (*P*~*association*~ = 0.043, Bonferroni-corrected *P*~association~ = 0.258, FDR-corrected *P*~*association*~ = 0.043) subgroups under the `TT` vs. `GG`+`GT` model. These data suggested that the *IL1A* rs17561 `G/T` polymorphism seems not be related to a risk for autoimmune disease overall.

![Meta-analysis of the *IL1A* rs17561 `G/T` polymorphism and the risk of autoimmune diseases under allele `T` vs. `G` model.](pone.0198693.g002){#pone.0198693.g002}

10.1371/journal.pone.0198693.t002

###### Meta-analysis of *IL1A* rs17561 `G/T` and rs1800587 `C/T` polymorphism.

![](pone.0198693.t002){#pone.0198693.t002g}

  SNP         Genetic models        N    Case/Control   *P*~association~   *P*~association~^&^   *P*~association~^\#^   ORs (95% CIs)       I^2^ (%)   *P*~heterogeneity~   F/R   *P*~Begg~   *P*~Egger~
  ----------- --------------------- ---- -------------- ------------------ --------------------- ---------------------- ------------------- ---------- -------------------- ----- ----------- ------------
  rs17561     allele `T` vs. `G`    11   2,561/2,099    0.576              1.000                 0.703                  0.93 (0.71, 1.21)   76.1       \<0.001              R     1.000       0.950
              carrier `T` vs. `G`   11   2,561/2,099    0.586              1.000                 0.703                  0.94 (0.75, 1.18)   56.2       0.011                R     0.876       0.724
              `TT` vs. `GG`xs       10   2,536/2,055    0.909              1.000                 0.909                  0.97 (0.59, 1.59)   51.4       0.029                R     1.000       0.368
              `GT` vs. `GG`         11   2,561/2099     0.419              1.000                 0.703                  0.89 (0.67, 1.18)   64.4       0.002                R     0.161       0.393
              `GT`+`TT` vs. `GG`    11   2,561/2,099    0.438              1.000                 0.703                  0.88 (0.65, 1.21)   72.2%      \<0.001              R     0.640       0.668
              `TT` vs. `GG`+`GT`    10   2,536/2,055    0.043              0.258                 0.258                  0.79 (0.64, 0.99)   44.9       0.060                F     0.858       0.289
  rs1800587   allele `T` vs. `C`    31   7,381/4,049    0.548              1.000                 0.860                  1.04 (0.92, 1.18)   76.5       \<0.001              R     0.634       0.396
              carrier `T` vs. `C`   31   7,381/4,049    0.546              1.000                 0.860                  1.03 (0.93, 1.14)   54.7       \<0.001              R     0.683       0.502
              `TT vs. CC`           29   7.179/3,794    0.860              1.000                 0.860                  1.02 (0.81, 1.28)   54.7       \<0.001              R     1.000       0.499
              `CT vs. CC`           31   7,381/4,049    0.747              1.000                 0.860                  1.03 (0.87, 1.21)   74.7       \<0.001              R     0.919       0.915
              `CT+TT vs. CC`        31   7,381/4,049    0.672              1.000                 0.860                  1.04(0.88, 1.22)    77.4       \<0.001              R     0.734       0.662
              `TT vs. CC+CT`        29   7.179/3794     0.698              1.000                 0.860                  1.04(0.86, 1.25)    38.2       0.020                R     0.866       0.481

**Note:** SNP, single nucleotide polymorphisms; N, number of case-control study; ORs, odd ratios; CIs, confidence intervals; *P*~*association*~, *P* value of association test; &, Bonferroni-corrected *P*~association~ value; \#, FDR-corrected *P*~association~ value; F, fixed; R, random.

10.1371/journal.pone.0198693.t003

###### Subgroup analysis of *IL1A* rs17561 `G/T` polymorphism.
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  Genetic models        subgroup    N    Case/Control   *P*~association~   *P*~association~^&^   *P*~association~^\#^   ORs (95% CIs)       I^2^(%)   *P*~heterogeneity~
  --------------------- ----------- ---- -------------- ------------------ --------------------- ---------------------- ------------------- --------- --------------------
  Allele `T` vs. `G`    Caucasian   7    2,253/1,777    0.811              1.000                 0.811                  1.02 (0.85, 1.24)   53.4      0.045
                        Asian       4    308/322        0.258              1.000                 0.516                  0.94 (0.75, 1.18)   88.9      \<0.001
                        RA          7    2,238/1,767    0.593              1.000                 0.625                  1.06 (0.86, 1.32)   55.9      0.035
                        PB          11   2,561/2,099    0.576              1.000                 0.576                  0.93 (0.71, 1.21)   76.1      \<0.001
  carrier `T` vs. `G`   Caucasian   7    2,253/1,777    0.493              1.000                 0.493                  0.96 (0.86, 1.07)   0.0       0.570
                        Asian       4    308/322        0.279              1.000                 0.493                  0.54 (0.18, 1.64)   81.9      0.001
                        RA          7    2,238/1,767    0.612              1.000                 0.790                  0.97 (0.87, 1.09)   0.0       0.448
                        PB          11   2,561/2,099    0.586              1.000                 0.586                  0.94 (0.75, 1.18)   56.2      0.011
  `TT` vs. `GG`         Caucasian   7    2,253/1,777    0.851              1.000                 0.851                  1.05 (0.65, 1.69)   54.0      0.043
                        Asian       3    283.278        0.355              1.000                 0.710                  0.30 (0.02, 3.79)   58.4      0.090
                        RA          7    2,238/1,767    0.882              1.000                 0.882                  1.04 (0.63, 1.72)   45.5      0.088
                        PB          10   2,536/2,055    0.909              1.000                 0.909                  0.97 (0.59, 1.59)   51.4      0.029
  `GT` vs. `GG`         Caucasian   7    2,253/1,777    0.805              1.000                 0.805                  0.98 (0.86, 1.12)   0.0       0.444
                        Asian       4    308/322        0.280              1.000                 0.560                  0.50 (0.14, 1.77)   85.3      0.000
                        RA          7    2,238/1,767    0.694              1.000                 0.904                  1.04 (0.86, 1.25)   18.7      0.287
                        PB          11   2,561/2,099    0.419              1.000                 0.419                  0.89 (0.67, 1.18)   64.4      0.002
  `GT`+`TT` vs. `GG`    Caucasian   7    2,253/1,777    0.984              1.000                 0.984                  1.00 (0.84, 1.19)   24.9      0.239
                        Asian       4    308/322        0.262              1.000                 0.524                  0.45 (0.11, 1.82)   88.3      0.000
                        RA          7    2,238/1,767    0.657              1.000                 0.772                  0.45 (0.11, 1.82)   37.8      0.141
                        PB          11   2,561/2,099    0.438              1.000                 0.438                  0.88 (0.65, 1.21)   72.2      0.000
  `TT` vs. `GG`+`GT`    Caucasian   7    2,253/1,777    0.125              0.750                 0.125                  0.84 (0.67, 1.05)   52.2      0.051
                        Asian       3    283.278        0.024              0.144                 0.048                  0.21 (0.05, 0.81)   40.9      0.184
                        RA          7    2,238/1,767    0.123              0.738                 0.220                  0.83 (0.65, 1.05)   41.2      0.116
                        PB          10   2,536/2,055    0.043              0.258                 0.043                  0.79 (0.64, 0.99)   44.9      0.060

**Note:** RA, rheumatoid arthritis; PB, population-based control; ORs, odd ratios; CIs, confidence intervals; *P*~*association*~, *P* value of association test; &, Bonferroni-corrected *P*~association~ value; \#, FDR-corrected *P*~association~ value; *P*~heterogeneity~, *P* value of heterogeneity.

Meta-analysis of rs1800587 {#sec015}
--------------------------

A total of 31 case-control studies with 7,381 cases and 4,049 controls were used for meta-analysis of the *IL1A* rs1800587 `C/T` Polymorphisms. Pooled data from the overall population ([Table 2](#pone.0198693.t002){ref-type="table"}) presented the negative results under all comparison models (all *P*~*association*~ \>0.05, Bonferroni-corrected *P*~association~ \>0.05, FDR-corrected *P*~*association*~\>0.05). Nevertheless, the data from the GD (Graves' disease) subgroup analysis ([Table 4](#pone.0198693.t004){ref-type="table"}), comprising three studies, showed an increased risk in cases of autoimmune diseases compared with controls under the genetic models of allele `T` vs. `C` (*P*~*association*~\<0.001, Bonferroni-corrected *P*~association~ \<0.006, FDR-corrected *P*~*association*~ \<0.006, OR = 1.89, 95% CIs = 1.40, 2.55), carrier `T` vs. `C` (*P*~*association*~\<0.001, Bonferroni-corrected *P*~association~ \<0.006, FDR-corrected *P*~*association*~ \<0.006, OR = 1.60, 95% CIs = 1.30, 1.98), `CT` vs. `CC` (*P*~*association*~\<0.001, Bonferroni-corrected *P*~association~ \<0.006, FDR-corrected *P*~*association*~ \<0.006, OR = 1.94, 95% CIs = 1.38, 2.72), `CT`+`TT` vs.`CC` (*P*~*association*~ = 0.001, Bonferroni-corrected *P*~association~ = 0.006, FDR-corrected *P*~*association*~ = 0.006, OR = 2.12, 95% CIs = 1.38, 3.25). We did not observe a positive association between case and control groups in other subgroup analyses ([Table 4](#pone.0198693.t004){ref-type="table"}, all *P*~*association*~\>0.05). [Fig 3](#pone.0198693.g003){ref-type="fig"} and [S6](#pone.0198693.s006){ref-type="supplementary-material"}--[S8](#pone.0198693.s008){ref-type="supplementary-material"} Figs show the forest plots of the subgroup analysis by disease type under the models of allele `T` vs. `C`, carrier `T` vs. `C`, `CT`+`TT` vs.`CC` and `CT` vs. `CC`, respectively. [S9](#pone.0198693.s009){ref-type="supplementary-material"} and [S10](#pone.0198693.s010){ref-type="supplementary-material"} Figs show the forest plot data of subgroup analysis by ethnicity and control source under allele models. Based on the above data, the `C/T` genotype of *IL1A* rs1800587 `C/T` polymorphism is more likely to be statistically associated with an increased risk of Graves' disease, but not other autoimmune diseases, such as systemic sclerosis, juvenile idiopathic arthritis, rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus.

![Subgroup analysis by disease type of the association between *IL1A* rs1800587 `C/T` polymorphism and the risk of autoimmune diseases under allele `T` vs. `C` model.](pone.0198693.g003){#pone.0198693.g003}

10.1371/journal.pone.0198693.t004

###### Subgroup analysis of *IL1A* rs1800587 `C/T` polymorphism.
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  Genetic models        subgroup    N    Case/Control   *P*~association~   *P*~association~^&^   *P*~association~^\#^   ORs (95% CIs)        I^2^(%)   *P*~heterogeneity~
  --------------------- ----------- ---- -------------- ------------------ --------------------- ---------------------- -------------------- --------- --------------------
  allele `T` vs. `C`    Asian       10   1,939/1,419    0.465              1.000                 0.733                  1.10 (0.85, 1.43)    80.5      \<0.001
                        Caucasian   19   5,167/2,424    0.612              1.000                 0.733                  0.97 (0.85, 1.10)    65.5      \<0.001
                        SSc         5    558/699        0.441              1.000                 0.593                  0.83 (0.52, 1.33)    84.0      \<0.001
                        JIA         4    487/274        0.494              1.000                 0.593                  0.92 (0.71, 1.18)    28.1      0.244
                        RA          6    2,493/966      0.980              1.000                 0.980                  1.00 (0.81, 1.24)    66.7      0.010
                        MS          4    1,351/430      0.284              1.000                 0.568                  1.11 (0.76, 1.64)    7.4       0.356
                        GD          3    997/888        \<0.001            \<0.006               \<0.006                1.89 (1.40, 2.55)    52.5      0.122
                        SLE         5    911/452        0.071              0.426                 0.213                  0.87 (0.75, 1.01)    10.5      0.346
                        PB          30   7,021/3,981    0.582              1.000                 0.582                  1.04 (0.91, 1.18)    77.2      \<0.001
  carrier `T` vs. `C`   Asian       10   1,939/1,419    0.316              1.000                 0.677                  1.11 (0.90, 1.37)    61.8      0.005
                        Caucasian   19   5,167/2,424    0.451              1.000                 0.677                  0.96 (0.87, 1.06)    30.6      0.101
                        SSc         5    558/699        0.512              1.000                 0.614                  0.88 (0.59, 1.30)    71.5      0.007
                        JIA         4    487/274        0.385              1.000                 0.614                  0.91 (0.73, 1.13)    0.0       0.576
                        RA          6    2,493/966      0.680              1.000                 0.680                  0.97 (0.84, 1.12)    24.3      0.252
                        MS          4    1,351/430      0.494              1.000                 0.614                  1.05 (0.91, 1.22)    0.0       0.721
                        GD          3    997/888        \<0.001            \<0.006               \<0.006                1.60 (1.30, 1.98)    0.0       0.518
                        SLE         5    911/452        0.236              1.000                 0.614                  0.91 (0.78, 1.06)    0.0       0.718
                        PB          30   7,021/3,981    0.568              1.000                 0.787                  1.03 (0.93, 1.15)    56.2      \<0.001
  `TT` vs. `CC`         Asian       10   1,939/1,419    0.746              1.000                 0.746                  1.11 (0.60, 2.04)    69.5      0.001
                        Caucasian   18   5,096/2,357    0.651              1.000                 0.746                  0.95 (0.77, 1.18)    36.5      0.061
                        SSc         5    558/699        0.893              1.000                 0.893                  1.04 (0.58, 1.86)    44.6      0.125
                        JIA         4    487/274        0.334              1.000                 0.668                  0.78 (0.46, 1.30)    0.0       0.505
                        RA          6    2,493/966      0.876              1.000                 0.893                  0.97 (0.66, 1.43)    46.0      0.099
                        MS          4    1,351/430      0.660              1.000                 0.893                  1.13 (0.66, 1.91)    52.6      0.097
                        GD          2    866/700        0.032              0.192                 0.192                  3.72 (1.12, 12.39)   54.8      0.137
                        SLE         5    911/452        0.082              0.492                 0.246                  0.75 (0.55, 1.04)    0.0       0.773
                        PB          28   6,819/3,726    0.963              1.000                 0.963                  1.01 (0.80, 1.27)    36.5      0.061
  `CT` vs. `CC`         Asian       10   1,939/1,419    0.120              0.720                 0.360                  1.24 (0.94, 1.64)    69.2      0.001
                        Caucasian   19   5,167/2,424    0.327              1.000                 0.491                  0.92 (0.78, 1.09)    64.4      \<0.001
                        SSc         5    558/699        0.513              1.000                 0.770                  0.84 (0.50, 1.42)    77.5      0.001
                        JIA         4    487/274        0.795              1.000                 0.883                  0.94 (0.60, 1.48)    54.3      0.087
                        RA          6    2,493/966      0.883              1.000                 0.883                  0.98 (0.74, 1.29)    64.0      0.016
                        MS          4    1,351/430      0.351              1.000                 0.702                  1.15 (0.86, 1.53)    57.9      0.068
                        GD          3    997/888        \<0.001            \<0.006               \<0.006                1.94 (1.38, 2.72)    42.1      0.178
                        SLE         5    911/452        0.166              1.000                 0.498                  0.76 (0.51, 1.12)    70.9      0.008
                        PB          30   7,021/3,981    0.733              1.000                 0.826                  1.03 (0.87, 1.22)    75.5      \<0.001
  `CT`+`TT` vs. `CC`    Asian       10   1,939/1,419    0.237              1.000                 0.650                  1.20 (0.89, 1.63)    77.0      \<0.001
                        Caucasian   19   5,167/2,424    0.433              1.000                 0.650                  0.94 (0.79, 1.11)    67.3      \<0.001
                        SSc         5    558/699        0.473              1.000                 0.710                  0.81 (0.46, 1.43)    82.6      \<0.001
                        JIA         4    487/274        0.730              1.000                 0.876                  0.93 (0.62, 1.40)    48.4      0.121
                        RA          6    2,493/966      0.963              1.000                 0.963                  0.99 (0.75, 1.31)    66.8      0.010
                        MS          4    1,351/430      0.294              1.000                 0.588                  1.14 (0.89, 1.45)    45.5      0.138
                        GD          3    997/888        0.001              0.006                 0.006                  2.12 (1.38, 3.25)    63.7      0.063
                        SLE         5    911/452        0.139              1.000                 0.417                  0.78 (0.55, 1.09)    63.5      0.027
                        PB          30   7,021/3,981    0.680              1.000                 0.902                  1.04 (0.88, 1.23)    78.1      \<0.001
  `TT` vs. `CC`+`CT`    Asian       10   1,939/1,419    0.948              1.000                 0.948                  1.02 (0.60, 1.73)    62.9      0.004
                        Caucasian   18   5,096/2,357    0.684              1.000                 0.948                  0.97 (0.82, 1.14)    13.0      0.299
                        SSc         5    558/699        0.786              1.000                 0.794                  1.06 (0.69, 1.63)    14.0      0.325
                        JIA         4    487/274        0.503              1.000                 0.794                  0.84 (0.51, 1.39)    0.0       0.444
                        RA          6    2,493/966      0.723              1.000                 0.794                  0.94 (0.67, 1.31)    35.0      0.174
                        MS          4    1,351/430      0.794              1.000                 0.794                  1.08 (0.62, 1.86)    58.6      0.065
                        GD          2    866/700        0.001              0.006                 0.006                  2.97 (1.54, 5.72)    0.0       0.349
                        SLE         5    911/452        0.356              1.000                 0.794                  0.87 (0.64, 1.17)    0.0       0.688
                        PB          28   6,819/3,726    0.823              1.000                 0.794                  1.02 (0.85, 1.24)    38.8      0.020

**Note:** SSC, systemic sclerosis; JIA, juvenile idiopathic arthritis; RA, rheumatoid arthritis; MS, multiple sclerosis

GD, Graves' disease; SLE, systemic lupus erythematosus; PB, population-based control; ORs, odd ratios; CIs, confidence intervals.

*P*~*association*~, *P* value of association test; &, Bonferroni-corrected *P*~association~ value; \#, FDR-corrected *P*~association~ value; *P*~heterogeneity~, *P* value of heterogeneity.

Heterogeneity, bias and sensitivity {#sec016}
-----------------------------------

Apart from the `TT` vs. `GG`+`GT` comparison of rs17561, larger heterogeneity was detected ([Table 2](#pone.0198693.t002){ref-type="table"}, I^2^ \>50.0% or *P*~heterogeneity~ \>0.05), and random effect models were utilized. In addition, as shown in [Table 2](#pone.0198693.t002){ref-type="table"}, *P* value of Begg's test and Egger's test were \>0.05 in all genetic models, indicating the absence of large publication bias. The plot data are shown in [Fig 4](#pone.0198693.g004){ref-type="fig"} and [S11 Fig](#pone.0198693.s011){ref-type="supplementary-material"}. Furthermore, we believe our data are stable, because we did not observe any remarkable change of pooled ORs under any genetic models. The data for the allele `T` vs. `C` model of rs1800587 are shown in [Fig 5](#pone.0198693.g005){ref-type="fig"}, and other data are not shown.

![Begg's test and Egger's test for the allele `T` vs. `C` model of *IL1A* rs1800587 `C/T` polymorphism.\
(A) Begg's test; (B) Egger's test.](pone.0198693.g004){#pone.0198693.g004}

![Sensitivity analysis for the allele `T` vs. `C` model of *IL1A* rs1800587 `C/T` polymorphism.](pone.0198693.g005){#pone.0198693.g005}

Discussion {#sec017}
==========

Previously, the rs1800587 `C/T` SNP of *IL1A* gene was reported to not be linked to the risk or severity of systemic lupus erythematosus in a Spanish population \[[@pone.0198693.ref012]\], juvenile idiopathic arthritis in an Iranian population \[[@pone.0198693.ref015]\], and juvenile idiopathic arthritis in the UK \[[@pone.0198693.ref013]\]. *IL1A* rs17561 SNP was not associated with rheumatoid arthritis susceptibility in a Mexican population \[[@pone.0198693.ref014]\]. However, the *IL1A* rs1800587 and rs17561 SNPs were also reported to be associated with the risk of systemic sclerosis in a Japanese population \[[@pone.0198693.ref008]\]. The rs1800587 `C/T` SNP of *IL1A* gene has been related to susceptibility to systemic sclerosis in a Slovak Caucasian population \[[@pone.0198693.ref009]\], Graves' ophthalmopathy in an Iranian population \[[@pone.0198693.ref010]\], and Graves' disease in a Tunisian population \[[@pone.0198693.ref011]\]. Therefore, we first comprehensively explored the association between *IL1A* rs17561 and rs1800587 SNPs and the risk of overall autoimmune diseases using meta-analysis and subgroup analyses by characteristics of ethnicity, disease type and source of control.

In 2013, a meta-analysis was reported \[[@pone.0198693.ref017]\], investigating the genetic relationship between *IL1A* rs1800587 and rs17561 SNPs and the risk of systemic lupus erythematosus based on four case-control studies from three articles \[[@pone.0198693.ref012], [@pone.0198693.ref042], [@pone.0198693.ref048]\], which did not provide strong evidence for an association. In 2014, data from another meta-analysis containing four studies from three articles \[[@pone.0198693.ref012], [@pone.0198693.ref048], [@pone.0198693.ref051]\] supported a potential association for rs1800587 in Europeans \[[@pone.0198693.ref016]\]. In this study, we added another case-control study \[[@pone.0198693.ref053]\] to the subgroup meta-analysis of systemic lupus erythematosus for rs1800587, and observed a negative association.

In one meta-analysis of rheumatoid arthritis susceptibility\[[@pone.0198693.ref018]\], there were four case-control studies \[[@pone.0198693.ref032], [@pone.0198693.ref035], [@pone.0198693.ref038], [@pone.0198693.ref054]\] for rs1800587 and three case-control studies \[[@pone.0198693.ref034], [@pone.0198693.ref039], [@pone.0198693.ref043]\] for rs17561. No positive association between *IL1A* rs1800587 and rs17561 SNPs and the risk of rheumatoid arthritis was observed \[[@pone.0198693.ref018]\]. Here, we included more data for our updated meta-analysis and removed one case-control study \[[@pone.0198693.ref054]\], in which the genotype distribution of control group did not fulfill Hardy-Weinberg equilibrium. Seven case-control studies \[[@pone.0198693.ref014], [@pone.0198693.ref034], [@pone.0198693.ref036], [@pone.0198693.ref038], [@pone.0198693.ref039], [@pone.0198693.ref041], [@pone.0198693.ref043]\] were enrolled for the subgroup analysis of rs17561, and six case-control studies \[[@pone.0198693.ref014], [@pone.0198693.ref032], [@pone.0198693.ref035], [@pone.0198693.ref036], [@pone.0198693.ref038], [@pone.0198693.ref046]\] were used for rs1800587. Our pooled data with enhanced statistical power also indicated that the *IL1A* rs1800587 and rs17561 SNPs were not linked to the risk of rheumatoid arthritis, which was consistent with previous data \[[@pone.0198693.ref018]\].

Regarding multiple sclerosis susceptibility, in 2013, Huang et al. enrolled five case-control studies \[[@pone.0198693.ref033], [@pone.0198693.ref037], [@pone.0198693.ref044], [@pone.0198693.ref050], [@pone.0198693.ref055]\] for a meta-analysis of rs1800587 SNP and two case-control studies \[[@pone.0198693.ref047], [@pone.0198693.ref056]\] for meta-analysis of rs17561 SNP. However, negative association was reported for both s1800587 and rs17561 \[[@pone.0198693.ref019]\]. Here, due to the limitation of Hardy-Weinberg equilibrium, one case-control study \[[@pone.0198693.ref055]\] was excluded from our subgroup meta-analysis of rs1800587. We also found that the rs1800587 SNP was not linked to the risk of multiple sclerosis.

In 2010, Liu et al. investigated the genetic relationship between *IL1A* rs1800587 SNP and risk of Graves' disease via a meta-analysis and found a positive association in an Asian population \[[@pone.0198693.ref020]\]. Here, our data in the subgroup meta-analysis of Graves' disease showed similar results. It is possible that the rs1800587 SNP within the 5\'-flanking regulatory region of *IL1A* gene affects the normal production, secretion or function of interleukin-1.

Some limitations exist in our meta-analysis. First, we did not obtain strong evidence regarding the effect of rs1800587 and rs17561 SNPs for the risk of different types of autoimmune diseases, due to the limited number of included independent case-control studies. Only two case-control studies \[[@pone.0198693.ref030], [@pone.0198693.ref040]\] were included in the subgroup of Graves' disease under the homozygote and recessive models. Second, even though no remarkable publication bias was detected by our Begg's test and Egger's test, larger heterogeneity existed in the majority of comparisons. We observed a decreased level of heterogeneity in some subgroup analyses by disease type, such as the "rheumatoid arthritis, RA" subgroup of rs17561 and "multiple sclerosis, MS" subgroup of rs1800587. The factor of specific disease type may be involved in the source of heterogeneity. Further relevant researches with larger sample sizes were required. Third, we only acquired suitable case-control studies published in English. The outcome may be affected by the inclusion of unpublished articles, or articles published in another language. Fourth, it is worth analyzing the combined influence of different SNPs or cytokine genes, when more case-control studies become available.

Taken together, based on published articles in databases, our meta-analysis suggested that the rs1800587 polymorphism, rather than rs17561, within the *IL1A* gene, may be a genetic risk factor for Graves' disease. However, *IL1A* rs17561 or rs1800587 polymorphism seems not to be statistically linked to the risk of other analyzed autoimmune diseases, such as systemic sclerosis, juvenile idiopathic arthritis, rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus.

Supporting information {#sec018}
======================

###### Meta-analysis of *IL1A* rs17561 `G/T` polymorphism and the risk of autoimmune diseases under carrier `T` vs. `G` model.

(TIF)

###### 

Click here for additional data file.

###### Meta-analysis of *IL1A* rs17561 `G/T` polymorphism and the risk of autoimmune diseases under `TT` vs. `GG` model.

(TIF)

###### 

Click here for additional data file.

###### Meta-analysis of *IL1A* rs17561 `G/T` polymorphism and the risk of autoimmune diseases under `GT` vs. `GG` model.

(TIF)

###### 

Click here for additional data file.

###### Meta-analysis of *IL1A* rs17561 `G/T` polymorphism and the risk of autoimmune diseases under `GT`+`TT` vs. `GG` model.

(TIF)

###### 

Click here for additional data file.

###### Meta-analysis of *IL1A* rs17561 `G/T` polymorphism and the risk of autoimmune diseases under `TT` vs. `GG`+`GT` model.

(TIF)

###### 

Click here for additional data file.

###### Subgroup analysis by disease type of the association between *IL1A* rs1800587 `C/T` polymorphism and the risk of autoimmune diseases under carrier `T` vs. `C` model.

(TIF)

###### 

Click here for additional data file.

###### Subgroup analysis by disease type of the association between *IL1A* rs1800587 `C/T` polymorphism and the risk of autoimmune diseases under `CT`+`TT` vs. `CC` model.

(TIF)

###### 

Click here for additional data file.

###### Subgroup analysis by disease type of the association between *IL1A* rs1800587 `C/T` polymorphism and the risk of autoimmune diseases under `CT` vs. `CC` model.

(TIF)

###### 

Click here for additional data file.

###### Subgroup analysis by ethnicity of the association between IL1A rs1800587 `C/T` polymorphism and the risk of autoimmune diseases under allele `T` vs. `C` model.

(TIF)

###### 

Click here for additional data file.

###### Subgroup analysis by control source of the association between *IL1A* rs1800587 `C/T` polymorphism and the risk of autoimmune diseases under allele `T` vs. `C` model.

(TIF)

###### 

Click here for additional data file.

###### Begg's test and Egger's test for the allele `T` vs. `G` model of *IL1A* rs17561 `G/T` polymorphism.

\(A\) Begg's test; (B) Egger's test.

(TIF)

###### 

Click here for additional data file.

###### Meta-analysis of genetic association studies checklist.

(DOCX)

###### 

Click here for additional data file.

###### PRISMA 2009 checklist.

(DOC)

###### 

Click here for additional data file.

###### The search terms of database searching.

(DOC)

###### 

Click here for additional data file.
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